Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical usefulness of dual orexin receptor antagonism beyond insomnia: Neurological and psychiatric comorbidities
Matteo Carpi, Laura Palagini, Mariana Fernandes, et al.
Neuropharmacology (2023) Vol. 245, pp. 109815-109815
Open Access | Times Cited: 15

Showing 15 citing articles:

Clinical practice guidelines for switching or deprescribing hypnotic medications for chronic insomnia: results of European neuropsychopharmacology and sleep expert’s consensus group
Laura Palagini, Roberto Brugnoli, Bernardo M Dell' Osso, et al.
Sleep Medicine (2025) Vol. 128, pp. 117-126
Closed Access | Times Cited: 2
Early experience with the new DORA daridorexant in patients with insomnia disorder and comorbid mental disturbances: Results of a naturalistic study with 3 months follow‐up
Laura Palagini, Gaspare Alfì, Riccardo Gurrieri, et al.
Journal of Sleep Research (2024)
Closed Access | Times Cited: 4
Novel Urea-Containing Compounds as Orexin Receptor Agonists for Treating Sleep Disorders, Namely, Narcolepsy, Hypersomnia, and Sleep Apnea Syndrome
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2025) Vol. 16, Iss. 3, pp. 375-376
Closed Access
Early life stress and hormonal status influence orexin‐1 receptor expression in structures regulating cardiorespiratory responses to CO2
Stéphanie Fournier, Julie Plamondon, Denis Richard, et al.
Experimental Physiology (2025)
Open Access
A Preliminary Report on the Effects of Daridorexant in Patients with Comorbid Insomnia and Substance Use Disorders
Marco Di Nicola, Maria Pepe, Lorenzo Bonomo, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 378-378
Open Access
Nanoparticles targeting the central circadian clock: Potential applications for neurological disorders
Marion Le Meur, Jaime Pignatelli, Paolo Blasi, et al.
Advanced Drug Delivery Reviews (2025), pp. 115561-115561
Open Access
Cerebrospinal-fluid Orexin-A levels in different neurocognitive disorders: a comparison study
Susana Lozano-Tovar, Riccardo Cremascoli, Marzia Nuccetelli, et al.
Neurological Sciences (2025)
Open Access
Daridorexant treatment for chronic insomnia: a real-world retrospective single-center study
Mariana Fernandes, Fabio Placidi, Nicola Biagio Mercuri, et al.
Neurological Sciences (2024) Vol. 45, Iss. 7, pp. 3443-3448
Open Access | Times Cited: 3
The potential use of daridorexant in eating disorders: beyond the treatment of insomnia?
Alice Caldiroli, Letizia Maria Affaticati, Enrico Capuzzi, et al.
International Clinical Psychopharmacology (2024)
Closed Access | Times Cited: 3
Insomnia and the Orexinergic Pathway in the Link with Psychopathology: Effects of DORAs in Insomnia Comorbid with Mental Disturbances
Laura Palagini, Pierre A. Geoffroy, Gaspare Alfì, et al.
Current Sleep Medicine Reports (2024) Vol. 10, Iss. 2, pp. 119-131
Closed Access | Times Cited: 2
Novel Compounds as Orexin Receptor Agonists for Treating Sleep Disorders, Namely, Narcolepsy and Hypersomnia
Ram W. Sabnis
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 8, pp. 1178-1179
Open Access | Times Cited: 1
Orexin Receptor Antagonists for the Prevention and Treatment of Alzheimer’s Disease and Associated Sleep Disorders
Matteo Carpi, Nicola Biagio Mercuri, Claudio Liguori
Drugs (2024)
Open Access | Times Cited: 1
Effects of Approved Pharmacological Interventions for Insomnia on Mood Disorders: A Systematic Review.
Laura Palagini, Mario Miniati, Donatella Marazziti, et al.
PubMed (2024) Vol. 21, Iss. 5, pp. 385-402
Closed Access | Times Cited: 1
The Orexinergic System: Neurobiology and Clinical Implications
Shorouq Motwani, Avinash De Sousa
Annals of Indian Psychiatry (2024) Vol. 8, Iss. 2, pp. 89-92
Open Access
Orexants, Orexin Receptor Antagonists: Novel Therapeutic Agents for Insomnia Disorder
Akshitha Kandukuri, Haritha Pasupulati, Satyanarayana SV Padi
International Neuropsychiatric Disease Journal (2024) Vol. 21, Iss. 6, pp. 92-108
Open Access
Long-term physiological impact of PTSD on Yazidi women in Northern Iraq refugee camps
Rikas Saputra, Yenni Lidyawati, Rizky Andana Pohan, et al.
Journal of Taibah University Medical Sciences (2024) Vol. 19, Iss. 6, pp. 1117-1118
Open Access
Page 1

Scroll to top